解读慢性咳临床试验中安慰剂反应的影响
Mengru Zhang1,2, Bangyu Zhang3,2, Alyn H Morice1
1Centre for Clinical Science, Respiratory Medicine, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, UK.
ERJ open research
|October 29, 2024
概括
假药反应使慢性咳药物的临床试验复杂化. 了解其机制和实施战略解决方案对于开发有效的咳治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
- 神经科学是一个神经科学.
背景情况:
- 慢性咳是一种常见的疾病,治疗选择很少.
- 咳药物的临床试验因安慰剂效应而面临挑战.
- 安慰剂反应可以显著影响研究结果和药物批准.
研究的目的:
- 审查安慰剂反应对抗咳药物的临床试验的影响.
- 探索咳中安慰剂效应背后的机制.
- 在未来的药物开发中提出减轻安慰剂反应的策略.
主要方法:
- 临床试验和关于咳和安慰剂反应的研究的文献综述.
- 对药理学,心理学和神经生物学因素的分析.
- 讨论研究设计,终点选择和患者分层.
主要成果:
- 咳试验中的安慰剂反应是多方面的,涉及药理学,心理和非特异性影响.
- 现有的试验设计可能无法充分考虑安慰剂效应.
- 导致咳中安慰剂效应的具体机制尚未完全理解.
结论:
- 解决安慰剂反应对于准确评估抗咳药物至关重要.
- 需要改进研究设计,终点选择和患者选择.
- 需要进一步的研究,以更好地理解和管理咳临床试验中的安慰剂效应.
相关概念视频
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
01:20COPD: Pathogenesis and Clinical Features
238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
234
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
234